Search Within

Department of Medicine

  1. "Clinical Lymphoma, Myeloma and Leukemia"
Formats
  1. Meeting Abstract (260)
  2. Journal Article (57)
  3. Review (5)
  4. Editorial (2)
  5. Conference Paper (1)
  6. Guidelines (1)
  7. Research Letter (1)
Groups
  1. Hematologic Malignancies, Division of (323)
  2. Center for Hematologic Malignancies (301)
  3. Adult Leukemia (117)
  4. Myeloma (96)
  5. Survivorship Research (85)
  6. Hematologic Malignancies Research (82)

More Groups

People
  1. Sergio Giralt (60)
  2. Alexander Lesokhin (57)
  3. Heather Landau (53)
  4. Hani Hassoun (51)
  5. Malin Hultcrantz (50)
  6. Neha Korde (47)

More People

Years
  1. 2025 (5)
  2. 2024 (27)
  3. 2023 (58)
  4. 2022 (53)
  5. 2021 (37)
  6. 2020 (29)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (327)
Publishers
  1. Elsevier Inc. (327)

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advancing the management of CH, MDS, and AML from the first Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference
    Editorial

    Carraway, H. E.; Brunner, A. M.; Lai, C. E.; Luskin, M. R.; Park, J.; Perl, A. E.; Stein, E. M.; Wang, E. S.; Zeidan, A. M.; Zeidner, J. F.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • A first-in-human phase I study of LOXO-338, an oral selective Bcl-2 inhibitor, in patients with advanced hematologic malignancies
    Journal Article

    Kwiatek, M.; Murthy, G. S. G.; Hoffmann, M.; Tessoulin, B.; Danilov, A.; Alencar, A. J.; Shah, N. N.; Ghesquieres, H.; Le Gouill, S.; Jurczak, W.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • SOHO state of the art updates and next questions: Diffuse large B-cell lymphoma in older adults: A comprehensive review
    Review

    Iyengar, V.; Hamlin, P.; Torka, P.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Addition of elotuzumab to backbone treatment regimens for multiple myeloma: An updated meta-analysis of randomized clinical trials
    Journal Article

    Costa, B. A.; Costa, T. A.; Chagas, G. C. L.; Mouhieddine, T. H.; Richter, J.; Usmani, S. Z.; Mailankody, S.; Rajeeve, S.; Hashmi, H.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Influence of obesity on the efficacy and toxicity of patients undergoing autologous hematopoietic cell transplantation for lymphoma
    Journal Article

    Lin, A.; Pearl, N.; Flynn, J.; Devlin, S.; Dahi, P.; Perales, M. A.; Scordo, M.; Shah, G. L.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (ide-cel) versus standard regimens (SRs) in triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 sub-analysis of black patients
    Meeting Abstract

    Patel, K. K.; Rodríguez-Otero, P.; Nooka, A. K.; Callander, N. S.; Solomon, S. R.; Baz, R.; Sborov, D. W.; Gergis, U.; Badros, A. Z.; Giralt, S. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • A phase 1 trial of valemetostat in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) or acute lymphocytic leukemia (ALL)
    Meeting Abstract

    Erba, H. P.; Oluwole, O. O.; Bixby, D.; Rampal, R. K.; Fathi, A. T.; Paliwal, P.; Jin, J.; Inoue, A.; Daver, N.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Dose-optimization study of 3 starting doses of ponatinib: Long-term results from the OPTIC trial
    Meeting Abstract

    Cortes, J.; Deininger, M.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; McCloskey, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Pelabresib plus ruxolitinib combination therapy in jak inhibitor-naïve patients with myelofibrosis in the phase 3 MANIFEST-2 study: Preliminary evidence of bone marrow recovery
    Meeting Abstract

    Mascarenhas, J.; Rampal, R. K.; Vannucchi, A. M.; Gupta, V.; Oh, S. T.; Kuykendall, A. T.; Mesa, R.; Kiladjian, J. J.; Talpaz, M.; Kremyanskaya, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Pirtobrutinib in relapsed/refractory CLL/SLL: Results from BTK-naïve cohort in the phase 1/2 BRUIN study
    Meeting Abstract

    Wierda, W. G.; Eyre, T. A.; Lech-Maranda, E.; Roeker, L. E.; Patel, M.; Fukuhara, N.; Woyach, J. A.; Brown, J. R.; Patel, K.; Tam, C. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save